Kerry Jo Lee said tools like model-informed drug development meeting program could be applied to ultra-rare disease drug development. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
